000 01596 a2200421 4500
005 20250511192008.0
264 0 _c19920423
008 199204s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1992.10.4.599
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAllred, D C
245 0 0 _aHER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cApr 1992
300 _a599-605 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aCarcinoma in Situ
_xgenetics
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aImmunoenzyme Techniques
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aPrognosis
650 0 4 _aProto-Oncogenes
650 0 4 _aSurvival Analysis
700 1 _aClark, G M
700 1 _aTandon, A K
700 1 _aMolina, R
700 1 _aTormey, D C
700 1 _aOsborne, C K
700 1 _aGilchrist, K W
700 1 _aMansour, E G
700 1 _aAbeloff, M
700 1 _aEudey, L
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 10
_gno. 4
_gp. 599-605
856 4 0 _uhttps://doi.org/10.1200/JCO.1992.10.4.599
_zAvailable from publisher's website
999 _c1555005
_d1555005